deltatrials
Completed NA Interventional 2-arm NCT02476071

Evaluating Demand Generation for Safe Voluntary Male Circumcision (VMC) for HIV Prevention (Stylish Man), Rakai, Uganda

Evaluating Demand Generation (Stylish Man) for Safe Voluntary Male Circumcision (VMC) for HIV Prevention, Rakai, Uganda

Sponsor: Johns Hopkins Bloomberg School of Public Health

Conditions HIV
Updated 5 times since 2017 Last updated: Aug 30, 2021 Started: Jul 31, 2013 Primary completion: Nov 30, 2019 Completion: Nov 30, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates HIV and is currently completed. Johns Hopkins Bloomberg School of Public Health leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Jan 2017 – ~Jul 2017 · 6 months · monthly snapshot~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotUnknown Status~Oct 2021 – present · 54 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Oct 2021 — Present [monthly]

    Completed NA

    Status: Unknown StatusCompleted

  2. Jan 2021 — Oct 2021 [monthly]

    Unknown Status NA

  3. Jun 2018 — Jan 2021 [monthly]

    Unknown Status NA

  4. Jul 2017 — Jun 2018 [monthly]

    Unknown Status NA

    Status: Active Not RecruitingUnknown Status

  5. Jan 2017 — Jul 2017 [monthly]

    Active Not Recruiting NA

    First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Johns Hopkins Bloomberg School of Public Health
  • Rakai Health Sciences Program
Data source: Johns Hopkins Bloomberg School of Public Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations